Literature DB >> 16356167

Lipid phosphate phosphatase-1 regulates lysophosphatidic acid- and platelet-derived-growth-factor-induced cell migration.

Jaclyn S Long1, Kazuaki Yokoyama, Gabor Tigyi, Nigel J Pyne, Susan Pyne.   

Abstract

LPPs (lipid phosphate phosphatases) are members of a family of enzymes that catalyse the dephosphorylation of lipid phosphates. The only known form of regulation of this family of enzymes is via de novo expression of LPP isoforms in response to growth factors. In this respect, we evaluated the effect of moderate increases in the expression of recombinant LPP1 on signal transduction by both G-protein-coupled receptors and receptor tyrosine kinases. We present evidence for a novel role of LPP1 in reducing PDGF (platelet-derived growth factor)- and lysophosphatidic acid-induced migration of embryonic fibroblasts. We demonstrate that the overexpression of LPP1 inhibits cell migration by reducing the PDGF-induced activation of p42/p44 MAPK (mitogen-activated protein kinase). This appears to occur via a mechanism that involves the LPP1-induced down-regulation of typical PKC (protein kinase C) isoform(s), which are normally required for PDGF-induced activation of p42/p44 MAPK and migration. In this regard, DAG (diacylglycerol) levels are high and sustained in cells overexpressing LPP1, suggesting a dynamic interconversion of phosphatidic acid into DAG by LPP1. This may account for the effects of LPP1 on cell migration, as sustained DAG is known to down-regulate PKC isoforms in cells. Therefore the physiological changes in the expression levels of LPP1 might represent a heterologous desensitization mechanism for attenuating PKC-mediated signalling and regulation of cell migration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16356167      PMCID: PMC1408680          DOI: 10.1042/BJ20051674

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Pulmonary lipid phosphate phosphohydrolase in plasma membrane signalling platforms.

Authors:  M Nanjundan; F Possmayer
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

2.  G-protein-coupled receptor stimulation of the p42/p44 mitogen-activated protein kinase pathway is attenuated by lipid phosphate phosphatases 1, 1a, and 2 in human embryonic kidney 293 cells.

Authors:  F Alderton; P Darroch; B Sambi; A McKie; I S Ahmed; N Pyne; S Pyne
Journal:  J Biol Chem       Date:  2001-01-17       Impact factor: 5.157

3.  Tethering of the platelet-derived growth factor beta receptor to G-protein-coupled receptors. A novel platform for integrative signaling by these receptor classes in mammalian cells.

Authors:  F Alderton; S Rakhit; K C Kong; T Palmer; B Sambi; S Pyne; N J Pyne
Journal:  J Biol Chem       Date:  2001-05-18       Impact factor: 5.157

4.  Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility.

Authors:  J P Hobson; H M Rosenfeldt; L S Barak; A Olivera; S Poulton; M G Caron; S Milstien; S Spiegel
Journal:  Science       Date:  2001-03-02       Impact factor: 47.728

5.  Identification of structurally important domains of lipid phosphate phosphatase-1: implications for its sites of action.

Authors:  Q X Zhang; C S Pilquil; J Dewald; L G Berthiaume; D N Brindley
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

6.  Cell surface activities of the human type 2b phosphatidic acid phosphatase.

Authors:  T Ishikawa; M Kai; I Wada; H Kanoh
Journal:  J Biochem       Date:  2000-04       Impact factor: 3.387

Review 7.  Integral membrane lipid phosphatases/phosphotransferases: common structure and diverse functions.

Authors:  Yury J Sigal; Mark I McDermott; Andrew J Morris
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

8.  Sequential actions of phospholipase D and phosphatidic acid phosphohydrolase 2b generate diglyceride in mammalian cells.

Authors:  V A Sciorra; A J Morris
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

9.  Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independent.

Authors:  S B Hooks; W L Santos; D S Im; C E Heise; T L Macdonald; K R Lynch
Journal:  J Biol Chem       Date:  2000-10-19       Impact factor: 5.157

10.  The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation.

Authors:  Sravan K Goparaju; Puneet S Jolly; Kenneth R Watterson; Meryem Bektas; Sergio Alvarez; Sukumar Sarkar; Lin Mel; Isao Ishii; Jerold Chun; Sheldon Milstien; Sarah Spiegel
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

View more
  10 in total

1.  The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo.

Authors:  Maria S Aguzzi; Debora Faraone; Daniela D'Arcangelo; Francesco De Marchis; Gabriele Toietta; Domenico Ribatti; Alberto Parazzoli; Paolo Colombo; Maurizio C Capogrossi; Antonio Facchiano
Journal:  Mol Ther       Date:  2010-10-05       Impact factor: 11.454

Review 2.  Lipid phosphate phosphatases and their roles in mammalian physiology and pathology.

Authors:  Xiaoyun Tang; Matthew G K Benesch; David N Brindley
Journal:  J Lipid Res       Date:  2015-03-26       Impact factor: 5.922

3.  Functional characterization of the atypical integral membrane lipid phosphatase PDP1/PPAPDC2 identifies a pathway for interconversion of isoprenols and isoprenoid phosphates in mammalian cells.

Authors:  Sumitra Miriyala; Thangaiah Subramanian; Manikandan Panchatcharam; Hongmei Ren; Mark I McDermott; Manjula Sunkara; Tracy Drennan; Susan S Smyth; H Peter Spielmann; Andrew J Morris
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

4.  Phospholipase Cgamma activation drives increased production of autotaxin in endothelial cells and lysophosphatidic acid-dependent regression.

Authors:  Eunok Im; Ruta Motiejunaite; Jorge Aranda; Eun Young Park; Lorenzo Federico; Tae-im Kim; Timothy Clair; Mary L Stracke; Susan Smyth; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2010-03-15       Impact factor: 4.272

Review 5.  Lipid phosphate phosphatases and signaling.

Authors:  David N Brindley; Carlos Pilquil
Journal:  J Lipid Res       Date:  2008-12-09       Impact factor: 5.922

Review 6.  Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy.

Authors:  David N Brindley; Fang-Tsyr Lin; Gabor J Tigyi
Journal:  Biochim Biophys Acta       Date:  2012-08-29

Review 7.  Phosphatidate degradation: phosphatidate phosphatases (lipins) and lipid phosphate phosphatases.

Authors:  David N Brindley; Carlos Pilquil; Meltem Sariahmetoglu; Karen Reue
Journal:  Biochim Biophys Acta       Date:  2009-02-27

8.  Identification of Arx targets unveils new candidates for controlling cortical interneuron migration and differentiation.

Authors:  Gaëlle Friocourt; John G Parnavelas
Journal:  Front Cell Neurosci       Date:  2011-12-27       Impact factor: 5.505

9.  Diverse Effects of Lysophosphatidic Acid Receptors on Ovarian Cancer Signaling Pathways.

Authors:  Hadil Onallah; Ben Davidson; Reuven Reich
Journal:  J Oncol       Date:  2019-09-17       Impact factor: 4.375

Review 10.  Lipid Phosphate Phosphatases and Cancer.

Authors:  Xiaoyun Tang; David N Brindley
Journal:  Biomolecules       Date:  2020-09-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.